FDA.reportPublic FDA data

Application 090313

Type
ANDA
Sponsor
ECI PHARMS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SODIUM POLYSTYRENE SULFONATESODIUM POLYSTYRENE SULFONATEPOWDER;ORAL, RECTAL453.6GM/BOTNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
17856-0831Sodium Polystyrene SulfonateSodium Polystyrene SulfonateATLANTIC BIOLOGICALS CORP.ANDACurrent
17856-0831Sodium Polystyrene SulfonateSodium Polystyrene SulfonateATLANTIC BIOLOGICALS CORP.ANDACurrent
50488-5001Sodium Polystyrene SulfonateSodium Polystyrene SulfonateAlexso, IncANDACurrent
51293-831Sodium Polystyrene SulfonateSodium Polystyrene SulfonateECI Pharmaceuticals, LLCANDACurrent
51293-831Sodium Polystyrene SulfonateSodium Polystyrene SulfonateECI Pharmaceuticals, LLCANDACurrent
51293-831Sodium Polystyrene SulfonateSodium Polystyrene SulfonateECI Pharmaceuticals, LLCANDACurrent
51293-831Sodium Polystyrene SulfonateSodium Polystyrene SulfonateECI Pharmaceuticals, LLCANDACurrent
63629-2031Sodium Polystyrene SulfonateSodium Polystyrene SulfonateBryant Ranch PrepackANDACurrent
63629-2031Sodium Polystyrene SulfonateSodium Polystyrene SulfonateBryant Ranch PrepackANDACurrent
63629-2031Sodium Polystyrene SulfonateSodium Polystyrene SulfonateBryant Ranch PrepackANDACurrent
70166-712Sodium Polystyrene SulfonateSodium Polystyrene SulfonateLOHXAANDACurrent